Key Account Manager/Buffalo NY jobs in United States
cer-icon
Apply on Employer Site
company-logo

UCB · 18 hours ago

Key Account Manager/Buffalo NY

UCB is a global biopharmaceutical company focusing on neurology and immunology. They are seeking a Key Account Manager in Rare Diseases who will be responsible for exceeding sales objectives and implementing marketing initiatives to achieve sales goals while collaborating with cross-functional partners to meet customer needs.

BiotechnologyHealth CarePharmaceutical

Responsibilities

Exceed sales objectives by implementing marketing initiatives by developing and implementing business plans
Maximize impact by leveraging all available data sets and stakeholder input
Seek qualified leads and effectively profile new accounts, refine call planning/routing to optimize schedules
Working knowledge of the local managed care reimbursement
Emphasizes accountability and the highest standard of ethical conduct

Qualification

Biotechnology salesBiopharmaceutical salesCNS/neuroscience experienceRare/orphan drug experienceNew product launchManaged care reimbursementSales objectives achievementAccount profilingEthical conductCross-functional collaboration

Required

Bachelor's degree BA/BS
7+ years of Biotechnology/Biopharmaceutical sales experience
Proven, documented track record of delivering consistent sales results
Experience calling on customers at a variety of call points (i.e., academic centers, community-based hospitals and private practice offices) both in person and virtual
Working knowledge of the local managed care reimbursement
Emphasizes accountability and the highest standard of ethical conduct

Preferred

2 years of rare/orphan drug experience is highly preferred or significant sales experience in CNS/neuroscience
Promoting products specific to CNS/neuroscience, including epilepsy
New product launch experience
Specialty pharmacy/REMS experience

Company

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease.

Funding

Current Stage
Public Company
Total Funding
$201.75M
Key Investors
Financière de Tubize SAPaul Capital
2022-05-23Post Ipo Equity· $100.96M
2015-05-13Post Ipo Equity· $0.79M
2009-12-22Post Ipo Equity· $100M

Leadership Team

leader-logo
Jean-Christophe Tellier
CEO
linkedin
leader-logo
Stefanos Grammatikos
Senior Vice President - Head of CMC Development Sciences
linkedin
Company data provided by crunchbase